Protocol No.: CA057-1070-EAP

Title
Expanded Access Program for Mezigdomide (in combination with Carfilzomib/dex or Bortezomib/dex) For Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Principal Investigator
Veltri, Lauren
Phase
NA
Age Group
Adult
Applicable Disease Site
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Syed Abdul Mannan Shah
Clinical Research Specialist
Phone: +1 304-293-1683

View on ClinicalTrials.gov